Screener
SELLAS Life Sciences Group, Inc. SLS Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001390478-26-000012
FAQ
- What is SELLAS Life Sciences Group, Inc.'s restricted cash?
- SELLAS Life Sciences Group, Inc. (SLS) reported restricted cash of $100K in Q2 2026.
- How has SELLAS Life Sciences Group, Inc.'s restricted cash changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s restricted cash decreased by 0.0% year-over-year, from $100K to $100K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s restricted cash has grown at a 0.0% compound annual growth rate (CAGR), from $100K to $100K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about SELLAS Life Sciences Group, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude